OpenLegislation

Section 2 Minimum requirements for the quality systems for the performance of pharmacovigilance activities by marketing authorisation holdersF1

United Kingdom

Original text. Later amendments are not shown.

  1. 10Management of human resources
  2. 11Compliance management
  3. 12Record management and data retention
  4. 13Audit

Annotations

Textual amendments

F1

Regulation revoked in part (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(t) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)